CIK 0001566044 · Non-accelerated filer<br>Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453757789
- Phone
- (203) 433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Domzalski David PRESIDENT AND CEO | Shares withheld for taxes | −14,232 | $0.60 | $9K | 401,976 |
| 2026-03-31 | Stuart Iain CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −2,876 | $0.60 | $2K | 112,363 |
| 2025-12-31 | Zeronda Tyler CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −7,858 | $0.58 | $5K | 103,795 |
| 2025-12-31 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Shares withheld for taxes | −3,579 | $0.58 | $2K | 125,905 |
| 2025-12-31 | Domzalski David PRESIDENT AND CEO | Shares withheld for taxes | −12,684 | $0.58 | $7K | 416,208 |
| 2025-12-31 | Stuart Iain CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −2,448 | $0.58 | $1K | 115,239 |
| 2025-12-12 | Little Elisabeth Sandoval Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-12-12 | Basta Steven L Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-12-12 | BARBARI SHARON Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-12-12 | LEPORE PATRICK G Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-09-30 | Zeronda Tyler CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −3,420 | $0.34 | $1K | 111,653 |
| 2025-09-30 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Shares withheld for taxes | −3,581 | $0.34 | $1K | 129,484 |
| 2025-09-30 | Domzalski David PRESIDENT AND CEO | Shares withheld for taxes | −12,676 | $0.34 | $4K | 428,892 |
| 2025-09-30 | Stuart Iain CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −2,453 | $0.34 | $822 | 117,687 |
| 2025-06-30 | Zeronda Tyler CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −3,420 | $1.65 | $6K | 115,073 |
| 2025-06-30 | Stuart Iain CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −2,453 | $1.65 | $4K | 120,140 |
| 2025-06-30 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Shares withheld for taxes | −3,581 | $1.65 | $6K | 133,065 |
| 2025-06-30 | Domzalski David PRESIDENT AND CEO | Shares withheld for taxes | −12,676 | $1.65 | $21K | 441,568 |
| 2025-06-02 | Harsch Mutya CHIEF LEGAL OFFICER AND GC | Grant or award | +1,145 | $0.81 | $927 | 136,646 |
| 2025-06-02 | Domzalski David PRESIDENT AND CEO | Grant or award | +8,681 | $0.81 | $7K | 454,244 |
Page 2 of 6 · 113 trades